Department of Cardiac Surgery, Policlinico Tor Vergata, Tor Vergata University of Rome, Italy.
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):14-9. doi: 10.2459/JCM.0b013e32832f9fde.
Conducting system defects are common in patients with aortic valve disease. Aortic valve replacement may result in further conduction abnormalities requiring permanent pacemaker implantation. The aim of our study was to identify the incidence and predictors for postoperative 30-day permanent pacemaker implantation in patients undergoing isolated aortic valve replacement, and the effect of an accurate surgical technique in order to prevent permanent pacemaker implantation.
Data from 261 consecutive patients (mean age 69 +/- 12 years, 136 men) undergoing isolated aortic valve replacement from January 2004 to January 2008 were analyzed retrospectively. Indications for aortic valve replacement were aortic valve stenosis (n = 156), stenoinsufficiency (n = 63), regurgitation (n = 42). Aortic bicuspid valve was present in 25% of cases (n = 64), redo operation was the indication in 7% (n = 18). Preoperative conducting system disease, defined as first-degree atrioventricular block, left or right bundle-branch block or left anterior hemiblock, was present in 25.6% (n = 67) of patients. An accurate surgical technique for debridement of calcific material was performed.
In-hospital mortality was 0.8% (2 out of 261 patients). Postoperatively, 8 out of 261 patients (3%) required permanent pacemaker implantation, for second-degree (n = 1) or complete atrioventricular block (n = 7). Incidence of permanent pacemaker implantation was similar for patients either with or without preoperative conducting system disease (25 vs. 25.7%, P = NS). Independent predictors of permanent pacemaker implantation were greater preoperative end-systolic diameter (P = 0.026) and left ventricular septum hypertrophy (P = 0.041).
Need of permanent pacemaker implantation after aortic valve replacement seems to be related more to preoperative advanced aortic valve disease rather than pre-existing conducting system abnormalities. An accurate surgical technique for aortic valve replacement probably helps to prevent further impairment of conducting system function requiring early postoperative permanent pacemaker implantation.
主动脉瓣疾病患者常存在传导系统缺陷。主动脉瓣置换术可能导致进一步的传导异常,需要植入永久性起搏器。我们的研究目的是确定在接受单纯主动脉瓣置换术的患者中,术后 30 天内植入永久性起搏器的发生率和预测因素,以及准确的手术技术对预防永久性起搏器植入的效果。
回顾性分析 2004 年 1 月至 2008 年 1 月期间连续 261 例(平均年龄 69 +/- 12 岁,男性 136 例)接受单纯主动脉瓣置换术的患者资料。主动脉瓣置换的适应证为主动脉瓣狭窄(n = 156)、狭窄不全(n = 63)、反流(n = 42)。主动脉瓣二叶畸形占 25%(n = 64),再次手术为适应证的占 7%(n = 18)。术前传导系统疾病定义为一度房室传导阻滞、左或右束支传导阻滞或左前分支阻滞,占 25.6%(n = 67)。采用准确的手术技术清除钙化物质。
院内死亡率为 0.8%(2 例/261 例患者)。术后 261 例患者中有 8 例(3%)需要植入永久性起搏器,其中 2 例为二度(n = 1),7 例为完全性房室传导阻滞(n = 7)。有或无术前传导系统疾病的患者植入永久性起搏器的发生率相似(25%与 25.7%,P = NS)。永久性起搏器植入的独立预测因素为术前收缩末期直径较大(P = 0.026)和左室间隔肥厚(P = 0.041)。
主动脉瓣置换术后需要植入永久性起搏器似乎与术前晚期主动脉瓣疾病有关,而与术前存在的传导系统异常关系不大。准确的主动脉瓣置换术技术可能有助于防止进一步损害传导系统功能,从而需要术后早期植入永久性起搏器。